Biogen Pays $124 Million to Develop Gene-Based Therapies

Biogen

Biogen Pays $124 Million to Develop Gene-Based Therapies

On Thursday, Biogen Inc. will enter into the area of eye-disease treatment by paying Applied Genetic Technologies Corp. (AGTC) about $124 million for licensing its products, and commercialization rights to a few of its gene-based therapies.

Where, the amount ($124 million) incorporates a $30 million equity investment worth of $20.63 per share. Biogen also has the choice to licensing discovery programs for three additional symptoms. The company plans to develop gene-based therapies for a range of eye diseases.

AGTC is qualified to get point of milestone payments summing up to $1 billion, incorporating up to $472.5 million for the two lead projects, and a large portion of the rest coming from payments for the potential discovery programs.

The two lead projects include in the agreement are a pre-clinical treatment for X-Linked Retinitis Pigmentosa, and a clinical candidate for a disease called X-linked Retinoschisis. These are diseases of the retina, which can cause visual impairment in men.

AGTC Chief Executive Sue Washer said that the combined effort would bolster the development of new treatments, which may consider transformative medications for these rare inherited eye diseases.

Alachua, Fla-based AGTC specializes in developing gene-therapy medicines for eye diseases. The therapy is still in its nascent stages. The most common type of the treatment takes healthy DNA, bundles it inside of a vector; a biological delivery mechanism; and after that delivers the vector into the body to supplant infected genes with the healthy DNA.

Massachusetts-based Biogen has been looking for new products to increase sales growth, after experiencing a successful 2013 launch of its various multiple-sclerosis therapies – Tecfidera. In its most recent quarter, slowing growth of Tecfidera led to lower than expected profit, and revenue growth.

Market Review: Shares of Biogen have increased sales of about 19 per cent, this year through Wednesday’s close. The deal is expected to shut down in the third quarter of the year. In recent trading, the shares of AGTC climbed to 17 per cent, while the shares of Biogen were relatively flat.

Avatar
Carrie Ann
Carrie Ann is Editor-in-Chief at Industry Leaders Magazine, based in Las Vegas. Carrie covers technology, trends, marketing, brands, productivity, and leadership. When she isn’t writing she prefers reading. She loves reading books and articles on business, economics, corporate law, luxury products, artificial intelligence, and latest technology. She’s keen on political discussions and shares an undying passion for gadgets. Follow Carrie Ann on Twitter, Facebook

Recent Posts

Elior acquires Nestor, the single meal food delivery startup

Elior acquires Nestor, the single meal food delivery startup

Elior, the corporate catering company, has acquired the French startup Nestor for an undisclosed amount. Nestor, a Paris, France-based food delivery service, started in 2015 with a
2 days ago
Axa gears to buy office space worth €800m in European cities

Axa gears to buy office space worth €800m in European cities

Axa Investment Managers, the French fund house, is not too worried about predictions that the post-pandemic world will see more people working from home and office real estates shr
2 days ago
ShareChat raises $502 million at $2 billion valuation

ShareChat raises $502 million at $2 billion valuation

ShareChat, the Indian owner of short video app Moj, has raised $502 million in the series E round of funding, pushing its value at $2.1 billion in the market. The five-year-old com
3 days ago
Small business groups form coalition to lobby for strong antitrust laws

Small business groups form coalition to lobby for strong antitrust laws

Small merchant groups are coming together to rally for strong antitrust laws to prevent big conglomerates like Amazon from swallowing up the smaller traders and businesses. Trade g
3 days ago
Vitol’s profit soars during 2020 oil crisis

Vitol’s profit soars during 2020 oil crisis

The world’s largest independent oil trader Vitol made record profits in 2020 as the fluctuations in the global energy markets resulted in a windfall. Vitol suffered an $85 billio
4 days ago
Seadrill proposes debt write off of $4.8 billion

Seadrill proposes debt write off of $4.8 billion

Seadrill Ltd., a deepwater drilling contracting company, owned by billionaire John Fredriksen, said it is ready to write off a debt of over $4.8 billion, giving lenders a 99 perce
5 days ago